STONY BROOK, N.Y., July 25 /PRNewswire-FirstCall/ -- Applied DNA Sciences, Inc. , a DNA security solutions company, announced today the completion of its first contract with Dr. Suwelack Skin & Healthcare AG (“Suwelack”). Suwelack is recognized in Germany as the leader in the innovation, development and manufacture of biomatrices for cosmeceutical and healthcare applications.
On May 9, 2006, Suwelack adopted APDN’s SigNature(TM) Program as one of many new initiatives that complement its expansion into the North American market. APDN’s SigNature(TM) logo was printed with ink containing APDN’s encrypted botanical DNA technology, onto Suwelack’s annual supply of packaging and labels.
Dr. James A. Hayward, CEO of APDN, stated: “We believe that the completion of our first contract to supply DNA embedded packaging and labels for Suwelack is a strong indication that our DNA technology is ready-to-implement. The Suwelack project took less than 3 months from start to finish, including negotiations, design, technical specification, DNA embedment, printing and authentication validations.”
APDN’s forensic-based technology can also help to enhance the power of existing security technologies such as barcoding, RFIDs, smart cards, and optical memory-based ID systems without adding significant cost or change to operations and finished goods.
APDN also today announced that Dr. Stephane Shu Kin So has joined the scientific team at the APDN laboratories in Stony Brook. Dr. Shu Kin So received his Ph.D. in Molecular Genetics and Microbiology from State University of New York in Stony Brook and has considerable experience in molecular biology techniques, DNA cloning and genetic manipulations in bacteria. He also received his Bachelor of Science Degree in Biology from Binghamton University in Binghamton, New York.
Dr. Benjamin Liang, Strategic Technology Development Officer, stated: “The addition of Dr. Shu Kin So is critical to our authentication operations which are now fully functional. Our team provides services to governments and corporations, and continues to refine and shorten forensic authentication processes.”
About Applied DNA Sciences, Inc.
Applied DNA Sciences, Inc. (APDN) develops proprietary DNA-embedded security solutions that use plant DNA to verify authenticity and protect corporate and government agencies from counterfeiting, fraud, piracy, product diversion, identity theft and unauthorized intrusion into physical plant and databases. Our common stock is registered under Section 12(g) of the Securities Exchange Act of 1934 and is listed on the Over-The-Counter Bulletin Board under the symbol “APDN”. Contact: MeiLin Wan, Applied DNA Sciences, Inc., 25 Health Sciences Drive, Stony Brook, New York 11790; Tel: 631-444- 6370; Fax: 631-444.8848 http://www.ADNAS.com.
About Dr. Suwelack Skin & Healthcare AG
Dr. Suwelack Skin & Healthcare AG manufactures biomatrices for skin and healthcare for cosmeceutical and medical applications. Suwelack’s patented technology uses a freeze-drying process to gently extract water from natural raw materials, as a result of which the raw materials are preserved in a highly pure form. By using this technique the company is able to avoid using preservative agents, chemical cross-linking agents and perfumes and ensure the basis for skin compatibility. Contact: Nikolaus Uleer, Dr. Suwelack Skin & Healthcare AG, Josef-Suwelack-Strasse, 48727 Billerbeck, Germany Tel: +49-2543-72-247 Fax: +49-2543-72-365 http://www.skin-healthcare.com
The statements made by Applied DNA Sciences, Inc. may be forward-looking in nature and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements describe the Company’s future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of Applied DNA Sciences, Inc. Actual results could differ materially from those projected due to changes in interest rates, market competition, changes in the local and national economies, and various other factors detailed from time to time in Applied DNA Sciences’ SEC reports and filings, including our Form 10-KSB, filed on January 12, 2006, our subsequent Quarterly Reports on Form 10-QSB, and our Current Reports on Form 8-K . The Company undertakes no obligation to update publicly any forward- looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events.
Applied DNA Sciences, Inc.
CONTACT: MeiLin Wan of Applied DNA Sciences, Inc., +1-631-444-6370, fax:+1-631-444-8848
